Adipose Tissue-derived Stem Cell Therapy Market - Global Outlook and Forecast 2021-2027

April 2021 | 104 pages | ID: A1773A878322EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Adipose Tissue-derived Stem Cell Therapy in Global, including the following market information:

Global Adipose Tissue-derived Stem Cell Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Adipose Tissue-derived Stem Cell Therapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adipose Tissue-derived Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Adipose Tissue-derived Stem Cell Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Adipose Tissue-derived Stem Cell Therapy Market Segment Percentages, By Type, 2020 (%)

• Autologous Stem Cells
• Allogeneic Stem Cells

China Adipose Tissue-derived Stem Cell Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Adipose Tissue-derived Stem Cell Therapy Market Segment Percentages, By Application, 2020 (%)

• Therapeutic Application
• Research Application

Global Adipose Tissue-derived Stem Cell Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Adipose Tissue-derived Stem Cell Therapy Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Adipose Tissue-derived Stem Cell Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Adipose Tissue-derived Stem Cell Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• AlloCure
• Antria
• Celgene Corporation
• Cellleris
• Corestem
• Cytori Therapeutics
• Intrexon
• Mesoblast
• Pluristem Therapeutics
• Tissue Genesis
• BioRestorative Therapies
• Celltex Therapeutics Corporation
• iXCells Biotechnologies
• Pluristem Therapeutics
• Cyagen
• Lonza

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Adipose Tissue-derived Stem Cell Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Adipose Tissue-derived Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADIPOSE TISSUE-DERIVED STEM CELL THERAPY OVERALL MARKET SIZE

2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size: 2021 VS 2027
2.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Adipose Tissue-derived Stem Cell Therapy Players in Global Market
3.2 Top Global Adipose Tissue-derived Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Adipose Tissue-derived Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adipose Tissue-derived Stem Cell Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Adipose Tissue-derived Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adipose Tissue-derived Stem Cell Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Adipose Tissue-derived Stem Cell Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Adipose Tissue-derived Stem Cell Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Adipose Tissue-derived Stem Cell Therapy Market Size Markets, 2021 & 2027
  4.1.2 Autologous Stem Cells
  4.1.3 Allogeneic Stem Cells
4.2 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue & Forecasts
  4.2.1 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2021
  4.2.2 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2022-2027
  4.2.3 By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Adipose Tissue-derived Stem Cell Therapy Market Size, 2021 & 2027
  5.1.2 Therapeutic Application
  5.1.3 Research Application
5.2 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue & Forecasts
  5.2.1 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2021
  5.2.2 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2022-2027
  5.2.3 By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Adipose Tissue-derived Stem Cell Therapy Market Size, 2021 & 2027
6.2 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue & Forecasts
  6.2.1 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2021
  6.2.2 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2022-2027
  6.2.3 By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2027
  6.3.2 US Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.3.3 Canada Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.3.4 Mexico Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2027
  6.4.2 Germany Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.4.3 France Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.4.4 U.K. Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.4.5 Italy Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.4.6 Russia Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.4.7 Nordic Countries Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.4.8 Benelux Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2027
  6.5.2 China Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.5.3 Japan Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.5.4 South Korea Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.5.5 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.5.6 India Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2027
  6.6.2 Brazil Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.6.3 Argentina Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2027
  6.7.2 Turkey Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.7.3 Israel Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.7.4 Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027
  6.7.5 UAE Adipose Tissue-derived Stem Cell Therapy Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AlloCure
  7.1.1 AlloCure Corporate Summary
  7.1.2 AlloCure Business Overview
  7.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.1.4 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.1.5 AlloCure Key News
7.2 Antria
  7.2.1 Antria Corporate Summary
  7.2.2 Antria Business Overview
  7.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.2.4 Antria Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.2.5 Antria Key News
7.3 Celgene Corporation
  7.3.1 Celgene Corporation Corporate Summary
  7.3.2 Celgene Corporation Business Overview
  7.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.3.4 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.3.5 Celgene Corporation Key News
7.4 Cellleris
  7.4.1 Cellleris Corporate Summary
  7.4.2 Cellleris Business Overview
  7.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.4.4 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.4.5 Cellleris Key News
7.5 Corestem
  7.5.1 Corestem Corporate Summary
  7.5.2 Corestem Business Overview
  7.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.5.4 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.5.5 Corestem Key News
7.6 Cytori Therapeutics
  7.6.1 Cytori Therapeutics Corporate Summary
  7.6.2 Cytori Therapeutics Business Overview
  7.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.6.4 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.6.5 Cytori Therapeutics Key News
7.7 Intrexon
  7.7.1 Intrexon Corporate Summary
  7.7.2 Intrexon Business Overview
  7.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.4.4 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.7.5 Intrexon Key News
7.8 Mesoblast
  7.8.1 Mesoblast Corporate Summary
  7.8.2 Mesoblast Business Overview
  7.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.8.4 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.8.5 Mesoblast Key News
7.9 Pluristem Therapeutics
  7.9.1 Pluristem Therapeutics Corporate Summary
  7.9.2 Pluristem Therapeutics Business Overview
  7.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.9.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.9.5 Pluristem Therapeutics Key News
7.10 Tissue Genesis
  7.10.1 Tissue Genesis Corporate Summary
  7.10.2 Tissue Genesis Business Overview
  7.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.10.4 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.10.5 Tissue Genesis Key News
7.11 BioRestorative Therapies
  7.11.1 BioRestorative Therapies Corporate Summary
  7.11.2 BioRestorative Therapies Business Overview
  7.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.11.4 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.11.5 BioRestorative Therapies Key News
7.12 Celltex Therapeutics Corporation
  7.12.1 Celltex Therapeutics Corporation Corporate Summary
  7.12.2 Celltex Therapeutics Corporation Business Overview
  7.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.12.4 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.12.5 Celltex Therapeutics Corporation Key News
7.13 iXCells Biotechnologies
  7.13.1 iXCells Biotechnologies Corporate Summary
  7.13.2 iXCells Biotechnologies Business Overview
  7.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.13.4 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.13.5 iXCells Biotechnologies Key News
7.14 Pluristem Therapeutics
  7.14.1 Pluristem Therapeutics Corporate Summary
  7.14.2 Pluristem Therapeutics Business Overview
  7.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.14.4 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.14.5 Pluristem Therapeutics Key News
7.15 Cyagen
  7.15.1 Cyagen Corporate Summary
  7.15.2 Cyagen Business Overview
  7.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.15.4 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.15.5 Cyagen Key News
7.16 Lonza
  7.16.1 Lonza Corporate Summary
  7.16.2 Lonza Business Overview
  7.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Major Product Offerings
  7.16.4 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue in Global (2016-2021)
  7.16.5 Lonza Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Adipose Tissue-derived Stem Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Adipose Tissue-derived Stem Cell Therapy Market Drivers in Global Market
Table 3. Adipose Tissue-derived Stem Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Adipose Tissue-derived Stem Cell Therapy in Global Market
Table 5. Top Adipose Tissue-derived Stem Cell Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Adipose Tissue-derived Stem Cell Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Adipose Tissue-derived Stem Cell Therapy Product Type
Table 9. List of Global Tier 1 Adipose Tissue-derived Stem Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adipose Tissue-derived Stem Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Adipose Tissue-derived Stem Cell Therapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Adipose Tissue-derived Stem Cell Therapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Adipose Tissue-derived Stem Cell Therapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Adipose Tissue-derived Stem Cell Therapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2022-2027
Table 30. AlloCure Corporate Summary
Table 31. AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 32. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 33. Antria Corporate Summary
Table 34. Antria Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 35. Antria Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 36. Celgene Corporation Corporate Summary
Table 37. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 38. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 39. Cellleris Corporate Summary
Table 40. Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 41. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 42. Corestem Corporate Summary
Table 43. Corestem Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 44. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 45. Cytori Therapeutics Corporate Summary
Table 46. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 47. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 48. Intrexon Corporate Summary
Table 49. Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 50. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 51. Mesoblast Corporate Summary
Table 52. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 53. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 54. Pluristem Therapeutics Corporate Summary
Table 55. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 56. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 57. Tissue Genesis Corporate Summary
Table 58. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 59. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 60. BioRestorative Therapies Corporate Summary
Table 61. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 62. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 63. Celltex Therapeutics Corporation Corporate Summary
Table 64. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 65. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 66. iXCells Biotechnologies Corporate Summary
Table 67. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 68. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 69. Pluristem Therapeutics Corporate Summary
Table 70. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 71. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 72. Cyagen Corporate Summary
Table 73. Cyagen Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 74. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)
Table 75. Lonza Corporate Summary
Table 76. Lonza Adipose Tissue-derived Stem Cell Therapy Product Offerings
Table 77. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Adipose Tissue-derived Stem Cell Therapy Segment by Type
Figure 2. Adipose Tissue-derived Stem Cell Therapy Segment by Application
Figure 3. Global Adipose Tissue-derived Stem Cell Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue in 2020
Figure 8. By Type - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 12. US Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 16. Germany Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 24. China Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 30. Brazil Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 33. Turkey Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Adipose Tissue-derived Stem Cell Therapy Revenue, (US$, Mn), 2016-2027
Figure 37. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Antria Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)